Columbia Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.33M Sell
61,560
-664
-1% -$63.6K 1.02% 29
2025
Q4
$5.98M Buy
62,224
+688
+1% +$66.8K 1.06% 24
2025
Q3
$5.86M Buy
61,536
+1,315
+2% +$121K 1.1% 24
2025
Q2
$5.25M Buy
60,221
+4,130
+7% +$350K 1.03% 27
2025
Q1
$5.04M Buy
56,091
+2,455
+5% +$220K 0.99% 31
2024
Q4
$4.28M Sell
53,636
-1,410
-3% -$122K 0.78% 37
2024
Q3
$4.96M Buy
55,046
+5,254
+11% +$442K 0.86% 35
2024
Q2
$3.92M Buy
49,792
+16,852
+51% +$1.38M 0.73% 42
2024
Q1
$2.71M Hold
32,940
0.55% 48
2023
Q4
$2.71M Buy
32,940
+3,103
+10% +$236K 0.55% 48
2023
Q3
$2.34M Buy
29,837
+35
+0.1% +$2.93K 0.52% 48
2023
Q2
$2.63M Buy
29,802
+6,645
+29% +$572K 0.56% 47
2023
Q1
$1.87M Buy
23,157
+9,332
+68% +$761K 0.42% 58
2022
Q4
$1.07M Buy
13,825
+276
+2% +$22.4K 0.26% 70
2022
Q3
$1.09M Sell
13,549
-2,202
-14% -$198K 0.29% 66
2022
Q2
$1.41M Buy
+15,751
New +$1.6M 0.36% 62
2021
Q4
$1.89M Sell
18,282
-3,926
-18% -$455K 0.38% 58
2021
Q3
$2.78M Sell
22,208
-350
-2% -$45.3K 0.61% 47
2021
Q2
$2.8M Sell
22,558
-14,028
-38% -$1.76M 0.62% 47
2021
Q1
$4.32M Buy
36,586
+1,160
+3% +$136K 0.78% 37
2020
Q4
$4.15M Buy
35,426
+2,775
+8% +$305K 0.84% 37
2020
Q3
$3.39M Buy
32,651
+730
+2% +$73.3K 0.78% 38
2020
Q2
$2.93M Buy
31,921
+9,095
+40% +$872K 0.7% 43
2020
Q1
$2.06M Buy
22,826
+537
+2% +$57.1K 0.51% 45
2019
Q4
$25.3K Buy
22,289
+3,450
+18% +$379K 0.61% 46
2019
Q3
$2.05M Hold
18,839
0.53% 49
2019
Q2
$1.83M Hold
18,839
0.48% 49
2019
Q1
$1.72M Buy
18,839
+119
+0.6% +$10.7K 0.46% 50
2018
Q4
$1.7M Hold
18,720
0.52% 48
2018
Q3
$1.84M Buy
18,720
+300
+2% +$27.7K 0.48% 52
2018
Q2
$1.58M Sell
18,420
-300
-2% -$25.1K 0.46% 57
2018
Q1
$1.5M Hold
18,720
0.44% 58
2017
Q4
$1.51M Sell
18,720
-500
-3% -$40K 0.43% 58
2017
Q3
$1.5M Hold
19,220
0.46% 55
2017
Q2
$1.71M Buy
19,220
+528
+3% +$44.5K 0.55% 54
2017
Q1
$1.5M Hold
18,692
0.5% 55
2016
Q4
$1.33M Hold
18,692
0.45% 55
2016
Q3
$1.61M Buy
18,692
+96
+0.5% +$8.37K 0.57% 53
2016
Q2
$1.61M Buy
18,596
+78
+0.4% +$6.31K 0.57% 51
2016
Q1
$1.39M Buy
18,518
+250
+1% +$18.8K 0.51% 55
2015
Q4
$1.41M Hold
18,268
0.56% 48
2015
Q3
$1.22M Sell
18,268
-2,570
-12% -$189K 0.5% 56
2015
Q2
$1.54M Sell
20,838
-1,000
-5% -$76.4K 0.59% 52
2015
Q1
$1.7M Hold
21,838
0.64% 45
2014
Q4
$1.58M Hold
21,838
0.61% 50
2014
Q3
$1.35M Sell
21,838
-200
-0.9% -$12.7K 0.55% 52
2014
Q2
$1.41M Buy
22,038
+200
+0.9% +$12.2K 0.57% 55
2014
Q1
$1.34M Hold
21,838
0.58% 56
2013
Q4
$1.25M Buy
+21,838
New +$1.24M 0.55% 60

Other funds holding MDT

Columbia Asset Management's MDT Position: Q1 2026 in Review

Columbia Asset Management reduced its Medtronic (MDT) stake by 1.1% in Q1 2026, selling an estimated $63.6K and leaving 61,560 shares worth $5.33M. The position accounts for 1.02% of the portfolio, ranked #29.

Columbia Asset Management first reported a position in MDT in Q4 2013 and has held it in 49 quarters since. The position peaked at $5.98M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Columbia Asset Management held 61,560 shares of Medtronic worth $5.33M as of Q1 2026.
  • Columbia Asset Management sold 664 Medtronic shares in Q1 2026, an estimated $63.6K.
  • Medtronic made up 1.02% of Columbia Asset Management's portfolio in Q1 2026, its #29 holding.
  • Columbia Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 49 quarters since.
  • Columbia Asset Management's Medtronic position peaked at $5.98M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Columbia Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.